Gutteridge C, Kuhn R J
Pediatr Nurs. 1994 May-Jun;20(3):278-9.
Dornase alfa is the first new drug released in 30 years for the treatment of patients with CF. Although it does not represent a replacement for current standard therapies, it is an effective agent in improving lung function. The development of this drug has helped to provide treatment to a medical problem that physicians have struggled with treating for years.
多纳酶α是30年来首个获批用于治疗囊性纤维化（CF）患者的新药。尽管它并非现有标准疗法的替代药物，但却是改善肺功能的有效药物。这种药物的研发有助于解决医生多年来一直难以治疗的医学难题。
